Prostate cancer (PCa) is the fourth most common cancer in the world and treatment is currently based on surgical removal and/or radiotherapy and/or hormone therapy. In the last few years' immunotherapy has become an important cancer treatment option. While the principles of immunotherapy evolved,...
According to Dr. Raman, "This image-guided therapy maximizes our ability to killcancer cellswhile minimizingcollateral damageto the prostate to achieve the ultimate trifecta inprostate cancer treatment: full local cancer control while maintaining urinary continence and potency. The latter are the complic...
Prostate cancer is the most common form of cancer in men in Western countries. There are approximately 1.1 million new cases around the world per year, and approx. 310,000 die from prostate cancer (GLOBOCAN). There was over four times the incidence of prostate cancer in 2017 as in the 195...
LOS ANGELES, May 26, 2023 /PRNewswire/ -- City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced it would present research on promising treatments for blood...
immunotherapy is a well-known treatment strategy for cancer that can enhance the existing anti-tumor response so that immune cells can restrict the growth of malignant cells. Again, immunotherapy can effectively target the cancer cells while causing minimal adverse effects [2,3]. Moreover, to prov...
In recent years the pace of research in prostate cancer has increased dramatically. Creative ideas in combination with new and emerging technologies have led to an explosion of discovery. These types of advances in prostate cancer research presage an era of new treatment strategies based on an unde...
CancerConnect Scroll to Continue Prostate Cancer Treatment High-Risk Prostate Cancer: Study Highlights Role of Advanced Imaging Advanced imaging technique called PSMA-PET more sensitive at detecting cancer spread in high-risk hormone-sensitive prostate cancer By Dr. C.H. Weaver M.D.Jan 10...
New strategies for the treatment of hormone-independent prostate cancer. J Buon 2002; 7: 107-12.Newling, DWW (2000) New strategies for the treatment of hormone-independent prostate cancer. Prostate cancer and prostatic diseases 3: pp. 290-295...
Keck Medicine of the University of Southern California (USC) scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface proteins called G-protein co
Levels of PSA, a protein produced by both normal and cancerous cells in the prostate gland, are often elevated in men with prostate cancer. As such, PSA is frequently used as both a screening tool and a biomarker to assess whether men with the disease might be responding to treatment. ...